Patricia S Moskwa

Title: Patricia S Moskwa: Innovator in Gene Expression Inhibition

Introduction

Patricia S Moskwa is a notable inventor based in Phoenixville, PA (US). She has made significant contributions to the field of gene expression inhibition, holding a total of 3 patents. Her work focuses on developing innovative compounds and methods that have the potential to impact medical science.

Latest Patents

Moskwa's latest patents include groundbreaking inventions such as "Oligonucleotide analogues containing phosphate diester linkage." This invention relates to compounds, compositions, and methods for inhibiting gene expression. The compounds comprise oligonucleoside sequences ranging from about 6 to about 200 bases, featuring a three-atom internucleoside linkage. Another significant patent is for "Nuclease resistant compounds," which discloses methods for inhibiting gene expression using oligonucleotide sequences of similar lengths, specifically those with diols at either or both termini. Preferred diols in this invention are polyalkyleneglycols, particularly polyethyleneglycols. These patents also include pharmaceutical compositions that utilize these compounds and methods for administering them to mammals.

Career Highlights

Throughout her career, Patricia has worked with prominent companies such as Sterling Drug Inc. and Sanofi. Her experience in these organizations has contributed to her expertise in the field of biotechnology and pharmaceuticals.

Collaborations

Some of her notable coworkers include Fred T Oakes and Frederick H Hausheer. Their collaboration has likely enriched her research and development efforts.

Conclusion

Patricia S Moskwa's innovative work in gene expression inhibition showcases her dedication to advancing medical science through her patented inventions. Her contributions continue to influence the field and highlight the importance of research in biotechnology.